MRNA241108C54000
- 0.01
- 0.000.00%
Moderna Newsroom
Barclays lowered moderna's target price to $111.
Gelonghui November 12th | Barclays: The target price of moderna is lowered from $125 to $111, maintaining a "shareholding" rating. (Gelonghui)
Moderna Options Spot-On: On November 11th, 142.03K Contracts Were Traded, With 645.55K Open Interest
On November 11th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 142.03K options for the day, of which put options accounted for 60.77% of the total transactions,
The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big
Moderna Down Nearly 7%, on Track for Lowest Close Since April 2020 -- Data Talk
Section Hosts Salesforce CEO & AI Leaders From Moderna and S&P Global in Free Virtual Conference
Express News | Moderna Shares Hit Lowest Level Since 2020, Last Down 4%
India's Business Standard Reported New Study Claims Mpox Clade La Has Evolved To Spread From Human To Human, Citing October 24 Uploaded Paper On Virologica
Moderna's MRESVIA Vaccine Gains Health Canada Approval
14 Out of 18 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Earnings Scorecard: About 50% of Companies That Reported Earnings This Week Beat Estimates
Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $60 to $112
S&P 500 Closes Just Shy of Record 6,000 Amid Strong Post-Election Rally
Moderna Options Spot-On: On November 8th, 136.34K Contracts Were Traded, With 626.34K Open Interest
On November 8th ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 136.34K options for the day, of which put options accounted for 42.45% of the total transactions,
Unusual Options Activity: PDD, NTES and Others Attract Market Bets, PDD V/OI Ratio Reaches 117.6
EST Nov 8th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Moderna Price Target Cut to $111.00/Share From $125.00 by Barclays
Moderna Is Maintained at Overweight by Barclays
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
Smart Money Is Betting Big In MRNA Options
BofA Securities Adjusts Price Target on Moderna to $90 From $110, Maintains Neutral Rating